Gastric Carcinoma in Autoimmune Gastritis: A Histopathologic and Molecular Study
Modern Pathology · 2024-06 · 37 (6) · 100491
DOI: 10.1016/j.modpat.2024.100491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2024-06. Verfasst von Valentina Angerilli und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Surgical Pathology Unit, University of Padua, Padua, Italy. Hauptthemen laut MEDLINE: Stomach Neoplasms, Gastritis, Autoimmune Diseases. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Veneto Region.
Abstract (Originalsprache)
Patients with autoimmune gastritis (AIG) have a 13-fold risk of developing type-1 neuroendocrine tumors, whereas the risk for gastric adenocarcinoma is still uncertain. Here we describe the clinicopathologic and molecular features of a series of gastric carcinomas (GC) arising in the context of AIG. A total of 26 AIG-associated GC specimens were collected from 4 Italian Institutions. Immunohistochemistry for MUC1, MUC2, MUC5AC, MUC6, CDX2, HER2, PD-L1, CLDN18, mismatch repair (MMR) proteins, and p53 and EBV-encoded RNA (EBER) in situ hybridization were performed. Histologic and immunohistochemical features were jointly reviewed by 5 expert gastrointestinal pathologists. Next-generation sequencing analysis (TrueSight Oncology 500, Illumina) of 523 cancer-related genes was performed on 19 cases. Most tumors were diagnosed as pT1 (52%) and they were located in the corpus/fundus (58%) and associated with operative link for gastritis assessment stage II gastritis (80.8%), absence of parietal cells, complete intestinal metaplasia, and enterochromaffin-like-cell micronodular hyperplasia. Only 4 (15.4%) GCs were diagnosed during follow-up for AIG. The following histotypes were identified: 20 (77%) adenocarcinomas; 3 (11%) mixed neuroendocrine-non-neuroendocrine neoplasms, and 2 (8%) high-grade solid adenocarcinomas with focal neuroendocrine component, 1 (4%) adenocarcinoma with an amphicrine component. Overall, 7 cases (27%) showed MMR deficiency, 3 (12%) were positive (score 3+) for HER2, 6 (23%) were CLDN18 positive, and 11 (42%) had PD-L1 combined positive score ≥ 10. EBER was negative in all cases. Molecular analysis revealed 5/19 (26%) microsatellite instability (MSI) cases and 7 (37%) tumor mutational burden (TMB) high. The most frequently altered genes were TP53 (8/19, 42%), RNF43 (7/19, 37%), ERBB2 (7/19, 37% [2 amplified and 5 mutated cases]), ARID1A (6/19, 32%), and PIK3CA (4/19, 21%). In summary, AIG-associated GCs are often diagnosed at low stage in patients with longstanding misrecognized severe AIG; they often display a neuroendocrine component or differentiation, have relatively higher rates of MMR deficiency, and TMB high.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Surgical Pathology Unit, University of Padua, Padua, Italy.
- Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia, Pavia, Italy; Anatomic Pathology Unit, IRCCS San Matteo Hospital Foundation, Pavia, Italy.
- Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy.
- Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia, Pavia, Italy.
- Anatomic Pathology Unit, Department of Surgical Sciences and Integrated Diagnostics (DICS), University of Genova, Italy; Ospedale Policlinico San Martino, IRCCS for Oncology and Neuroscience, Genova, Italy.
- Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy; First Department of Internal Medicine, IRCCS San Matteo Hospital Foundation, Pavia, Italy.
Förderung
- Associazione Italiana per la Ricerca sul Cancro
- Veneto Region
Zitieren
APA
Angerilli, V., Vanoli, A., Celin, G., Ceccon, C., Gasparello, J., Sabbadin, M., De Lisi, G., Paudice, M., Lenti, M. V., Rovedatti, L., Di Sabatino, A., Bazzocchi, F., Lonardi, S., Savarino, E., Luchini, C., Parente, P., Grillo, F., Mastracci, L., & Fassan, M. (2024). Gastric Carcinoma in Autoimmune Gastritis: A Histopathologic and Molecular Study. Modern Pathology, 37(6), 100491. https://doi.org/10.1016/j.modpat.2024.100491
Vancouver
Angerilli V, Vanoli A, Celin G, Ceccon C, Gasparello J, Sabbadin M, et al. Gastric Carcinoma in Autoimmune Gastritis: A Histopathologic and Molecular Study. Modern Pathology. 2024;37(6):100491. doi:10.1016/j.modpat.2024.100491
BibTeX
@article{Angerilli2024,
author = {Angerilli, Valentina and Vanoli, Alessandro and Celin, Giulia and Ceccon, Carlotta and Gasparello, Jessica and Sabbadin, Marianna and De Lisi, Giuseppe and Paudice, Michele and Lenti, Marco Vincenzo and Rovedatti, Laura and Di Sabatino, Antonio and Bazzocchi, Francesca and Lonardi, Sara and Savarino, Edoardo and Luchini, Claudio and Parente, Paola and Grillo, Federica and Mastracci, Luca and Fassan, Matteo},
title = {Gastric Carcinoma in Autoimmune Gastritis: A Histopathologic and Molecular Study},
journal = {Modern Pathology},
year = {2024},
volume = {37},
number = {6},
pages = {100491},
doi = {10.1016/j.modpat.2024.100491}
}
EUVIMED